Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer therapy

An oncolytic circular RNA therapy

Nature Cancer volume 5, pages 5–7 (2024)Cite this article

Subjects

This article has been updated

In vitro-transcribed RNA is a promising emerging class of therapeutic, but the poor specificity of cargo RNAs so far has limited their application in cancer immunotherapy. A new study reports the delivery of a synthetic circular RNA with inline cis-acting translational elements — encoding an engineered, mitochondrion-specific oncolytic protein — that shows both therapeutic and prophylactic potential against adenocarcinoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Overview of adenocarcinoma treatment using circular RNA.

Change history

  • 14 February 2024

    In the version of the article initially published, several instances of "translated" and "translational" originally appeared as "transcribed" and "transcriptional". This has now been corrected in the HTML and PDF versions of the article.

References

  1. Sahin, U., Karikó, K. & Türeci, Ö. Nat. Rev. Drug Discov. 13, 759–780 (2014).

    Article  CAS  PubMed  Google Scholar 

  2. Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. Nat. Rev. Drug Discov. 17, 261–279 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hamilton, A. G., Swingle, K. L. & Mitchell, M. J. PLoS Biol. 21, e3002105 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Anderson, B. R. et al. Nucleic Acids Res. 39, 9329–9338 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jain, R. et al. Nucleic Acid Ther. 28, 285–296 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Van Hoecke, L. et al. Nat. Commun. 9, 3417 (2018).

    Article  PubMed  PubMed Central  ADS  Google Scholar 

  7. Feng, Z. et al. Nat. Cancer https://doi.org/10.1038/s43018-023-00650-8 (2023).

  8. Burdette, B. E., Esparza, A. N., Zhu, H. & Wang, S. Acta Pharm. Sin. B 11, 2768–2782 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yang, Y. & Wang, Z. J. Mol. Cell Biol. 11, 911–919 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Jahan, N., Wimmer, E. & Mueller, S. PloS One 8, e60791 (2013).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  11. Liu, Y., Cui, J., Hoffman, A. R. & Hu, J.-F. Cell Prolif. 56, e13367 (2023).

    Article  CAS  PubMed  Google Scholar 

  12. Wesselhoeft, R. A. et al. Mol. Cell 74, 508–520.e4 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023).

    Article  CAS  PubMed  Google Scholar 

  14. Stewart, T. L., Wasilenko, S. T. & Barry, M. J. Virol. 79, 1084–1098 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA

    Alex G. Hamilton & Michael J. Mitchell

  2. Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Michael J. Mitchell

  3. Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Michael J. Mitchell

  4. Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Michael J. Mitchell

  5. Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Michael J. Mitchell

  6. Institute for RNA Innovation, University of Pennsylvania, Philadelphia, PA, USA

    Michael J. Mitchell

Authors
  1. Alex G. Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Mitchell.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamilton, A.G., Mitchell, M.J. An oncolytic circular RNA therapy. Nat Cancer 5, 5–7 (2024). https://doi.org/10.1038/s43018-023-00627-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-023-00627-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing